Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Vicapsys Life Sciences, Inc. per 2024 Sep 30 adalah -1.11 MM.
- Nilai net income untuk Vicapsys Life Sciences, Inc. per 2024 Sep 30 adalah -1.35 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2024-09-30 | -1.11 | -1.35 | |
2024-06-30 | -1.09 | -1.35 | |
2024-03-31 | -1.04 | -1.30 | |
2023-12-31 | -1.05 | -1.18 | |
2023-09-30 | -0.67 | -1.08 | |
2023-06-30 | -0.64 | -0.98 | |
2023-03-31 | -0.69 | -1.03 | |
2022-12-31 | -0.64 | -0.98 | |
2022-09-30 | -0.60 | -0.60 | |
2022-06-30 | -0.56 | -0.56 | |
2022-03-31 | -0.45 | -0.45 | |
2021-12-31 | -0.34 | -0.24 | |
2021-09-30 | -0.31 | -0.21 | |
2021-06-30 | -0.29 | -0.19 | |
2021-03-31 | -0.45 | -0.35 | |
2020-12-31 | -0.77 | -0.77 | |
2020-09-30 | -0.93 | -0.93 | |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk Vicapsys Life Sciences, Inc. pada 2024 Sep 30 adalah -0.04.
- laba per saham yang terdilusi untuk Vicapsys Life Sciences, Inc. pada 2024 Sep 30 adalah -0.04.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2024-09-30 | -0.04 | -0.04 |
2024-06-30 | -0.04 | -0.04 |
2024-03-31 | -0.04 | -0.04 |
2023-12-31 | -0.03 | |
2023-09-30 | -0.03 | -0.03 |
2023-06-30 | -0.03 | -0.03 |
2023-03-31 | -0.03 | -0.03 |
2022-12-31 | -0.03 | |
2022-09-30 | -0.02 | -0.02 |
2022-06-30 | -0.02 | -0.02 |
2022-03-31 | -0.02 | -0.03 |
2021-12-31 | -0.01 | |
2021-09-30 | -0.01 | -0.01 |
2021-06-30 | -0.01 | -0.01 |
2021-03-31 | -0.02 | -0.02 |
2020-12-31 | -0.04 | |
2020-09-30 | -0.06 | -0.06 |
2020-06-30 | -0.09 | -0.09 |
2020-03-31 | -0.10 | -0.10 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Vicapsys Life Sciences, Inc. per 2024 Sep 30 adalah -0.13 MM.
- Nilai kas dari aktivitas pendanaan untuk Vicapsys Life Sciences, Inc. per 2024 Sep 30 adalah 0.16 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2024-09-30 | -0.13 | 0.16 | |
2024-06-30 | -0.19 | -0.04 | |
2024-03-31 | -0.42 | 0.41 | |
2023-12-31 | -0.42 | 0.41 | |
2023-09-30 | -0.33 | 0.36 | |
2023-06-30 | -0.27 | 0.48 | |
2023-03-31 | -0.13 | 0.03 | |
2022-12-31 | -0.24 | 0.03 | |
2022-09-30 | -0.36 | 0.00 | 0.23 |
2022-06-30 | -0.50 | 0.00 | 0.35 |
2022-03-31 | -0.49 | 0.00 | 0.56 |
2021-12-31 | -0.44 | 0.10 | 0.56 |
2021-09-30 | -0.32 | 0.10 | 0.39 |
2021-06-30 | -0.14 | 0.10 | 0.21 |
2021-03-31 | -0.10 | 0.10 | |
2020-12-31 | -0.26 | ||
2020-09-30 | -0.51 | 0.00 | |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2024-09-30 | |||
2024-06-30 | -13.07 | ||
2024-03-31 | -66.82 | -54.10 | -54.10 |
2023-12-31 | -81.37 | -65.88 | -65.88 |
2023-09-30 | 0.00 | 0.00 | |
2023-06-30 | 0.00 | 0.00 | 0.00 |
2023-03-31 | 0.00 | 0.00 | |
2022-12-31 | 0.00 | 0.00 | |
2022-09-30 | 0.00 | 0.00 | |
2022-06-30 | 0.00 | 0.00 | |
2022-03-31 | 0.00 | 0.00 | 0.00 |
2021-12-31 | 0.00 | 0.00 | 0.00 |
2021-09-30 | 0.00 | 0.00 | 0.00 |
2021-06-30 | |||
2021-03-31 | 0.00 | 0.00 | 0.00 |
2020-12-31 | 0.00 | 0.00 | 0.00 |
2020-09-30 | 0.00 | 0.00 | 0.00 |
2020-06-30 | 0.00 | 0.00 | 0.00 |
2020-03-31 | 0.00 | 0.00 | 0.00 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Vicapsys Life Sciences, Inc. pada 2024 Sep 30 adalah 0.00.
- EBIT (3 tahun) / EV untuk Vicapsys Life Sciences, Inc. pada 2024 Sep 30 adalah -0.04.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2024-09-30 | 0.00 | -0.04 |
2024-06-30 | -0.08 | -0.06 |
2024-03-31 | -0.01 | -0.01 |
2023-12-31 | -0.01 | -0.01 |
2023-09-30 | -30.93 | -18.21 |
2023-06-30 | 248.56 | 143.54 |
2023-03-31 | 22.74 | 17.82 |
2022-12-31 | 22.74 | 22.19 |
2022-09-30 | 32.51 | 32.98 |
2022-06-30 | 4.48 | 6.45 |
2022-03-31 | 1.09 | 2.80 |
2021-12-31 | 1.29 | 4.05 |
2021-09-30 | 1.12 | 3.90 |
2021-06-30 | ||
2021-03-31 | 15.25 | 54.84 |
2020-12-31 | -124.10 | -216.16 |
2020-09-30 | -161.58 | -103.88 |
2020-06-30 | -535.88 | -917.07 |
2020-03-31 | 52.53 | 94.59 |
Efektivitas Manajemen
- roa untuk Vicapsys Life Sciences, Inc. pada 2024 Sep 30 adalah 0.00.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2024-09-30 | 0.00 | ||||
2024-06-30 | -17.06 | ||||
2024-03-31 | -14.99 | ||||
2023-12-31 | -2.81 | ||||
2023-09-30 | -2.58 | ||||
2023-06-30 | -2.69 | ||||
2023-03-31 | -1.25 | ||||
2022-12-31 | -1.08 | ||||
2022-09-30 | -1.02 | ||||
2022-06-30 | -0.81 | ||||
2022-03-31 | -0.55 | ||||
2021-12-31 | -0.53 | ||||
2021-09-30 | -0.52 | ||||
2021-06-30 | -0.45 | ||||
2021-03-31 | -0.76 | ||||
2020-12-31 | -1.10 | -2.54 | |||
2020-09-30 | -0.98 | -1.71 | |||
2020-06-30 | -1.65 | ||||
2020-03-31 | -1.67 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 | 1.00 | -1.79 | -1.66 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1468639 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |